Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05178862 |
|---|---|
| Brief Title: | A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole (MARIO) |
| First Submitted : | December 16, 2021 |
| First Submitted that Met QC Criteria : | December 16, 2021 |
| First Posted : | January 5, 2022 |
| Last Update Submitted that Met QC Criteria : | November 14, 2023 |
| Last Update Posted : | November 18, 2023 |